InkVivo Technologies AG
PrivateLast Round
pre_seed
Aug 13, 2025
Total Funding Raised
$28,000
Company Overview
InkVivo Technologies AG operates in Healthcare & Life Sciences and is based in Lugano. Its latest recorded funding round was a pre_seed round in August 2025.
InkVivo Technologies AG is a biotechnology company that develops a next-generation drug delivery platform to improve therapeutic outcomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InkVivo Technologies AG Comparables
Compare InkVivo Technologies AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Catalya | 79% | |
| InnoCore Pharmaceuticals | 77% | |
| Sustained Therapeutics | 76% |
For institutional investors. Book with your work email.
InkVivo Technologies AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| pre_seed | Aug 13, 2025 | ||||
| Grant | Nov 13, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InkVivo Technologies AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TiVenture | pre_seed |
| Fondazione Agire | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 13, 2025
$1.23M round led by TiVenture
For institutional investors. Book with your work email.
InkVivo Technologies AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InkVivo Technologies AG's valuation, stock price, and market status.
Is InkVivo Technologies AG a public or private company?
InkVivo Technologies AG is a private company.
What is the current stock price of InkVivo Technologies AG?
InkVivo Technologies AG is a private company, so its shares have no public market price. Caplight tracks InkVivo Technologies AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InkVivo Technologies AG worth (valuation)?
Valuation information for InkVivo Technologies AG is not publicly available.
Can I buy InkVivo Technologies AG stock?
InkVivo Technologies AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InkVivo Technologies AG's last funding round?
InkVivo Technologies AG's most recent funding round was pre_seed on August 13, 2025.
Who are the main investors in InkVivo Technologies AG?
Key investors in InkVivo Technologies AG include TiVenture.
Will InkVivo Technologies AG IPO soon?
No public IPO plans have been announced for InkVivo Technologies AG.
How can I track InkVivo Technologies AG secondary market activity?
Caplight tracks bids, offers, and trades in InkVivo Technologies AG's shares on secondary markets.